FDAnews
www.fdanews.com/articles/152936-vestiq-pharmaceuticals-enters-into-exclusive-distribution-agreement-with-bmg-pharma-for-gelx-oral-gel-treatment-of-oral-mucositis

Vestiq Pharmaceuticals Enters Into Exclusive Distribution Agreement With BMG Pharma for GelX Oral Gel Treatment of Oral Mucositis

February 5, 2013
Vestiq Pharmaceuticals said that it has taken the rights for distribution of GelX Oral Gel from BMG Pharma GelX is an oral solution for the treatment and maintenance of Oral Mucositis most commonly caused by chemotherapy, radiotherapy and other related pharmacological therapies.
Marketwire